Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A squamous cell carcinoma arising from the oral cavity. It affects predominantly adults in their fifth and sixth decades of life and is associated with alcohol and tobacco use. Human papillomavirus is present in approximately half of the cases. It is characterized by a tendency to metastasize early to the lymph nodes. When the tumor is small, patients are often asymptomatic. Physical examination may reveal erythematous or white lesions or plaques. The majority of patients present with signs and symptoms of locally advanced disease including mucosal ulceration, pain, difficulty with speaking, chewing, and swallowing, bleeding, weight loss, and neck swelling. Patients may also present with swollen neck lymph nodes without any symptoms from the oropharyngeal tumor. The most significant prognostic factors are the size of the tumor and the lymph nodes status.
Biomarker and diagnostic research for oral cavity squamous cell carcinoma has been reported in the published literature.
93 clinical trials registered, 35 recruiting. Interventions under study include drug therapy, procedural interventions, other interventions, and biologic therapy. Pipeline includes 6 PHASE3, 40 PHASE2, 13 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06321003](https://clinicaltrials.gov/study/NCT06321003) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 4:05 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography |
— |
University of Palermo |
RECRUITING |
[NCT06336941](https://clinicaltrials.gov/study/NCT06336941) | "Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON) | NA | University of Pisa | RECRUITING |
[NCT06174428](https://clinicaltrials.gov/study/NCT06174428) | Validity of Viome's Oral/throat Cancer Test | — | Viome | RECRUITING |
[NCT04333537](https://clinicaltrials.gov/study/NCT04333537) | Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer | PHASE2 | NRG Oncology | RECRUITING |
[NCT05774483](https://clinicaltrials.gov/study/NCT05774483) | Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative | NA | Tata Memorial Hospital | RECRUITING |
235 publications have been identified in PubMed for oral cavity squamous cell carcinoma. Research spans Clinical Trial Publication (25%), Epidemiology / Natural History (23%), and Diagnostic / Biomarker (20%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 59 | 25% |
Disease patterns and progression | 55 | 23% |
Testing and diagnosis research | 47 | 20% |
Laboratory research | 33 | 14% |
Research summaries | 20 | 9% |
Patient case studies | 12 | 5% |
Other research | 9 | 4% |
Can S (2026). [PMID: 41222634](https://pubmed.ncbi.nlm.nih.gov/41222634/). *Eur Arch Otorhinolaryngol*. [Diagnostic / Biomarker]
Ferrero-Coloma SM (2026). [PMID: 42168667](https://pubmed.ncbi.nlm.nih.gov/42168667/). *Clin Oral Investig*. [Diagnostic / Biomarker]
Anjos RS (2026). [PMID: 41578901](https://pubmed.ncbi.nlm.nih.gov/41578901/). *Med Oral Patol Oral Cir Bucal*. [Basic Science / Preclinical]
Koch N (2026). [PMID: 41850038](https://pubmed.ncbi.nlm.nih.gov/41850038/). *Oral Oncol*. [Clinical Trial Publication]
Nissi L (2026). [PMID: 42285029](https://pubmed.ncbi.nlm.nih.gov/42285029/). *Am J Otolaryngol*. [Diagnostic / Biomarker]
Nemade H (2026). [PMID: 42143968](https://pubmed.ncbi.nlm.nih.gov/42143968/). *Oral Oncol*. [Diagnostic / Biomarker]
Ho AS (2026). [PMID: 41534318](https://pubmed.ncbi.nlm.nih.gov/41534318/). *Oral Oncol*. [Basic Science / Preclinical]
Singh A (2026). [PMID: 42105650](https://pubmed.ncbi.nlm.nih.gov/42105650/). *Eur J Surg Oncol*. [Clinical Trial Publication]
Hoxie HR (2026). [PMID: 41274504](https://pubmed.ncbi.nlm.nih.gov/41274504/). *J Biol Chem*. [Basic Science / Preclinical]
Useche M (2026). [PMID: 41719737](https://pubmed.ncbi.nlm.nih.gov/41719737/). *Oral Oncol*. [Clinical Trial Publication]
AI-curated news mentioning oral cavity squamous cell carcinoma
Updated Sep 1, 2026
A case report highlights a rare instance of cutaneous metastasis from oral squamous cell carcinoma, suggesting the potential role of GALR2 as a biomarker. This discovery could inform future research and diagnostic approaches in oncology.
A case report highlights an unusual cardiac metastasis from oral squamous cell carcinoma, contributing to the understanding of this rare phenomenon. The findings may inform future research and clinical approaches to similar cases.
A case report highlights the synchronous occurrence of oral squamous cell carcinoma and aggressive papillary thyroid microcarcinoma, along with regional metastasis in cervical lymph nodes. This finding may provide insights into the complex interactions between these cancers.